Search Results 61-70 of 16394 for pharmacogenetics
THe purpose of this study is to examine the current and (potential) future therapeutic relevance of pharmacogenomics (PGx) testing for a cohort of cancer ...
In the Right Drug, Right Dose, Right Time: Using Genomic Data to Individualize Treatment (RIGHT 10K) Study, Mayo Clinic collaborated with Baylor College of ...
Challenges in Determining Genotypes for Pharmacogenetics in Allogeneic Hematopoietic Cell Transplant Recipients. ... Pharmacogenetic workup of ...
Pharmacogenetics; Immunotherapy; Artificial intelligence in medicine. Clinical research. Mayo Clinic conducts hundreds of clinical trials for patients with both ...
Learn about the department and faculty of the PGY-2 Clinical Pharmacogenomics Residency at Mayo Clinic in Rochester, Minnesota.
Faculty and staff of the Pharmacogenomics Lab of Richard Weinshilboum, M.D., at Mayo Clinic's campus in Rochester, Minnesota.
This study recently used pharmacogenetic (PGx) data on 11,000 subjects within the Mayo Clinic Biobank as part of the Right Drug, Right Dose, Right Time ...
Now using pharmacogenomics testing, which looks at how a person's genetic traits affect their medication response, and a new gene verifier model, Dr. Diasio and ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. This research is being done to better understand how genetic information related to drug dosing and use can affect medical care of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Send a note of thanks to Mayo Clinic researchers who are revolutionizing healthcare and improving patient outcomes.